• FACTS 001 Trial: Questions and Answers

    Questions and answers about the FACTS 001 efficacy trial of the use of tenofovir vaginal gel among women in South Africa provide background on the study and information about its results and their implications.

  • HIV Prevention Study Does Not Confirm Tenofovir Gel Effectiveness

    Tenofovir vaginal gel was not effective in preventing HIV among a large, diverse population of young South African women, reports this press release from the Follow-on African Consortium for Tenofovir Studies. Less than a quarter of the participants were able to use the gel consistently. The press release discusses the results presented at the 2015 Conference on Retroviruses and Opportunistic Infections and their implications.